ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$2.48 USD
+0.12 (5.08%)
Updated Oct 13, 2025 04:00 PM ET
After-Market: $2.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
ImmunityBio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IBRX 2.48 +0.12(5.08%)
Will IBRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IBRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IBRX
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunityBio (IBRX) Moves to Buy: Rationale Behind the Upgrade
ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Other News for IBRX
IBRX forms Directional Movement Crossover Bearish on October 10
Undercovered Dozen: Petrobras, Richtech Robotics, Enbridge And More
Is IBRX likely to continue lower? Fell Below 50 Day Moving Average shows up after sliding 3.56%
Is IBRX gaining bearish strength? 20 Day Moving Average Resistance shows up after climbing 1.2%
50 Day Moving Average Support appears for IBRX after 1.19% move